Activating mutations in <i>Kirsten rat sarcoma viral oncogene homologue (KRAS)</i>, in particular, a point mutation leading to a glycine-to-cysteine substitution at codon 12 (G12C), are among the most frequent genomic alterations in non-small cell lung cancer (NSCLC). Here, KRAS is linked to non-small cell lung carcinoma.